Chromium Exposure And Lung Cancer: A Study On Tissue Chromium Concentrations In Smokers And Non-Smokers

Abstract

The objective of this research is to study the effects of chromium exposure on lung cancer through tissue chromium content analysis of cancerous and non-cancerous lungs. Atomic absorption spectroscopy is the main technique to measure chromium levels in analyzed tissues because it detects trace metals with high precision and accuracy (Rojiani & Rojiani, 2024). Research data indicated that lung cancer patients contained dramatically elevated chromium levels in their lung tissue compared to patients without cancer thus indicating possible links between chromium exposure and lung cancer development (Ghosh et al., 2020). Research showed that people who smoked as well as showed increased chromium levels in their tissues, which reinforces the idea that mixing chromium exposure with smoking behaviour leads to greater lung cancer risks (Boffetta et al., 2016). Chromium shows promise as a biomarker for detecting lung cancer because it strengthens the development of better screening methods (Das et al., 2018). Future investigations should employ non-invasive chromium testing methods and study how chromium exposure together with environmental and life-style elements such as smoking leads to complex lung cancer development (Jia et al., 2020). Better preventive measures together with diagnostic tools can be developed through increased comprehension of these NHS dynamics (IARC, 2012).